In 2025, the Swiss Federal Council decided to comprehensively revise the Reproductive Medicine Act (FMedG) to adapt it to changing societal settings. The focus is on legalizing egg donation and opening up egg and sperm donation to unmarried couples. The upcoming complete revision of the FMedG raises a number of fundamental and regulatory questions that have not yet been resolved. The Center for Life Sciences-Law (ZLSR) has been monitoring the dynamic development of reproductive medicine law for several years through international and interdisciplinary workshops. The current research project uses the ongoing legislative process for the reform of the FMedG as an opportunity to discuss the legal policy reform proposals from a legal and social science perspective. The results will be published in an edited volume and thus contributed to the political debate. By demonstrating a willingness to adapt reproductive medicine law in an innovative manner to new technological and societal settings, legislators and legal scholars are fulfilling their responsibility to critically monitor and shape the legal framework.

Link to the project description.

Events:

Workshop on the Revision of the Reproductive Medicine Act,
Key Points of a New Regulation, Basel, February 20 and 21, 2025

Webinar: Fortpflanzungsmedizin für alle? Basel, January 27 and 28, 2022

Public evening lecture: Kinderwunsch ohne Grenzen? Basel, January 26, 2022

Publications:

Fateh-Moghadam, B. (2024) «Kontingenz und Unverfügbarkeit - Zur Funktion des Fortpflanzungsmedizinverfassungsrechts», in I. Baur u.a. (Hrsg.) Entwicklungen im Medizinrecht - Vom klassischen Arztrecht zu One Health. Bern: Stämpfli Verlag (Festschrift für Brigitte Tag), S. 171–184

Fateh-Moghadam, B. (2023) «Fortpflanzungsmedizingesetz (FMedG)», in T. Poledna, V. Rumetsch (Hrsg.) Gesundheitsrecht. Band VIII/1. Basel: Helbing Lichtenhahn, S. 935–996.

Siegel V., Schurr C., Perler L., Bigler C. and Büchler T., Transnationale reproduktive Mobilität - empirische Befunde zu einer umstrittenen Praxis, H2R Workingpaper 3/2022

Pärli K. and Mahrer D. (2022), Sozialversicherungsrechtliche Aspekte, Möglichkeiten und Grenzen der Sozialversicherung, H2R Workingpaper 4/2022

Alex K. and Rehmann-Stutter C. (2022), Gibt es einen therapeutischen Imperativ zum Genome Editing in der menschlichen Keimbahn?, H2R Workingpaper 5/2022

Christen-Zihlmann V., Fildir T. and Yacoubian C. (2022), Tagungsbericht zum Workshop “Fortpflanzungsmedizin für alle", link to online publication